chartexchange

Roche launches newborn screening test for three severe genetic conditions

PR Newswire | Sep 30, 2026 1:00 AM EDT

This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) simultaneously. Catching these conditions shortly after birth empowers clinicians to choose life-changing...

Read original article